Neural restrictive silencer factor, NRSF (also known as REST) binds a neuronal cell type selective silencer element to mediate transcriptional repression of neuron-speci®c genes in non-neuronal cells and neuronal progenitors. Two repression domains (RD-1 and RD-2) occur in its N-terminal and C-terminal regions, respectively. RD-1 recruits mSin3 and HDAC, thereby inhibiting transcription by inducing reorganization of the chromatin structure. However, little is known about how such global repression becomes promoter-speci®c repression or whether the NRSF±HDAC complex can interact with transcriptional core factors at each speci®c promoter. Here we show evidence that NRSF interacts with core promoter factors, including TATAbinding protein (TBP). The NRSF±TBP interaction occurred between the linear segments of the Nand C-terminal-most portions of NRSF and the C-terminal half of TBP. A RD-2 mutant of NRSF lost the TBP-binding activity and was unable to repress transcription at an exogenously introduced TGTA promoter. These results indicate that the direct interaction between the NRSF C-terminal domain and TBP is essential for the C-terminal repression mechanism of NRSF. Thus, the RD-1 and RD-2 repression domains of NRSF utilize both chromatindependent and chromatin-independent mechanisms, which may be segregated at various stages of neural development and modulation.
INTRODUCTION
The regulation of chromatin structure is crucial for controlling gene expression by altering the accessibility of promoter elements to DNA-binding factors including enhancer and silencer factors and the general transcriptional machinery. Two classes of complexes work together to modulate the chromatin structure: ATP-dependent chromatin remodeling complexes and histone-modifying complexes. Histone acetyltransferase (HAT) or histone deacetylase (HDAC) complexes can change the chromatin folding through covalent modi®ca-tion of the histone tail. A simple model of transcription would be that sequence-speci®c regulators ®rst bind to the promoter, in conjunction with chromatin remodeling or modifying complexes, and then the core promoter factors are recruited to form an active initiation complex. However, the assembly of these protein complexes varies among different promoters and how chromatin-remodeling events regulate the promoter speci®city or cell type speci®city of transcription is obscure (1±3).
Neural restrictive silencer factor (NRSF) (4) , also known as RE-1 silencing factor (REST) (5) , functions as a transcriptional repressor of multiple neuron-speci®c genes in nonneuronal cells and tissues during neural development and in adulthood (6±8). Many target genes of NRSF relate directly to neuronal function, including ion channels, neurotransmitter synthetases, receptors, synaptosomal proteins, neuronal cell adhesion molecules, neuronal cytoskeleton, neurotrophic factors and neuronal growth-associated proteins (9) . NRSF is composed of an N-terminal repression domain (RD-1), a DNA-binding domain with eight consecutive zinc ®ngers followed by a highly basic region and a C-terminal repression domain (RD-2) containing a single zinc ®nger motif (10±12). There are several lines of evidence indicating that transcriptional regulation is concerned with the reorganization of chromatin structure through histone acetylation (13, 14) .
Recent studies revealed that NRSF repressed transcription by binding to co-repressor mSin3, thereby recruiting HDAC, through its N-terminal RD-1 (12,15±18) , whereas the C-terminal RD-2 was shown to bind to another co-repressor, CoREST (15) . More recent studies indicated that CoREST is a component of a novel HDAC complex (19, 20) and recruits HDAC2 to the NRS/RE1 of the Nav1.2 sodium channel gene (21) . Thus, both RD-1 and RD-2 are involved in HDACmediated chromatin remodeling, which could be a primary cause of the initiation of transcriptional repression of speci®c target genes. In spite of this notion, however, trichostatin A (TSA), an HDAC inhibitor, failed to derepress NRSF C-terminal domain-mediated repression of the transcription of the GluR2 glutamate receptor gene (17) and SCG10 gene (12) , thus suggesting that some unknown HDAC-independent repression mechanism(s) may exist for the C-terminus of NRSF in addition to a HDAC-dependent mechanism. Since HDAC generally affects only one or two histone octamers in chromatin (22) , the HDAC complex would be required to be brought to chromatin located near the target gene transcription initiation site(s). As to the repression activity of NRSF, it is thus anticipated that the NRSF±mSin3±HDAC complex would need to be recruited to the core promoter region from the silencer (NRSE) site. Therefore, we focused in this study on the interaction of NRSF with core promoter factors in NRSF-mediated transcriptional repression.
We show herein that the NRSF N-and C-terminal repression domains interact with TBP and some other factors and that inhibition of the interaction between the C-terminus of NRSF and TATA-binding protein (TBP) causes loss of the repression activity of this NRSF domain. Our results indicate that this NRSF±TBP interaction is an important mechanism for the transcriptional repression of neuronal genes via the C-terminal domain of NRSF in addition to the thus far known HDAC-dependent mechanism.
MATERIALS AND METHODS

Plasmid constructs
Plasmids encoding human TBP deletion constructs were a generous gift from P.Carlsson (Go Èteborg University, Sweden) (23) . To prepare additional TBP deletion constructs for in vitro translation, we ampli®ed inserts by PCR with 5¢ BamHI and 3¢ XhoI adapter primers and subcloned them into the unique BamHI and XhoI sites of pcDNA3. Mouse TFIIB cDNA was obtained by reverse transcription±PCR and subcloned into pcDNA3. The construction of glutathione S-transferase (GST)±NRSF fusion proteins, e.g. GST±NRSF-N (1±153) and GST±NRSF-C (989±1097), was previously described (12) . Similar GST fusion proteins containing various portions of NRSF were constructed by standard recombinant DNA methodology using the pGEX-5X vector (Amersham Pharmacia). The series of Gal4 DNA-binding domain (G4 DBD) (1±147)±NRSF fusion constructs used for a luciferase assay were described previously (12) . TBP AS expression vectors and a c-fos TGTA reporter plasmid were provided by W.Herr. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) (24).
GST pull-down and in vitro binding assays
The GST±NRSF fusion proteins were expressed in Escherichia coli BL21 and puri®ed and immobilized on glutathione± Sepharose beads (Amersham Pharmacia). 35 S-radiolabeled TBP and TFIIB were synthesized in vitro using a single tube, coupled transcription±translation system (Novagen). The 35 Slabeled proteins were incubated at 4°C for 1 h with a 50% slurry of immobilized GST fusion proteins in 1 ml of buffer A (phosphate-buffered saline containing 100 mM KCl and 0.25% NP40). The beads were then washed ®ve times with 1 ml of buffer A each time. The bound proteins were eluted into Laemmli's loading buffer, fractionated by SDS±PAGE and detected by autoradiography. For identi®cation of the NRSFbinding region on TBP, their respective deletion constructs were radiolabeled with [ 35 S]methionine and the GST pull-down assay was performed similarly to as described above. For analysis of the interactions of endogenous general transcription factors with NRSF-N and NRSF-C, GST fusion proteins were incubated with 100 mg of nuclear extract of NIH 3T3 cells in buffer B [20 mM Tris±HCl at pH 8.0, 150 mM NaCl, 0.5% NP40, 10% glycerol and protease inhibitor complete (Roche)]. Nuclear extracts were prepared as described earlier (25) . Bound proteins were analyzed by western blotting using anti-TBP antibody N-12 and anti-TFIIB antibody C-18 (all from Santa Cruz Biotechnology). Autoradiograms were quanti®ed using PhosphoImaging.
Immunoprecipitation and western blotting
HEK 293 cells were transfected with FLAG-tagged NRSF using Lipofectamine Plus reagent (Gibco-BRL). Nuclear extracts of HEK 293 cells transfected with FLAG-tagged NRSF were precleared by rotating at 4°C for 1 h with protein G±Sepharose beads in buffer C [20 mM Tris±HCl at pH 8.0, 150 mM NaCl, 0.1% NP40, 10% glycerol and protease inhibitor complete (Roche)]. Nuclear extracts were then recovered by centrifugation and added to 5 mg of anti-NRSF antibody (P-18). Immunoprecipitations were performed by rotation for 2 h or overnight at 4°C. Then protein G beads were added and after additional rotation for 2 h, the beads were washed three times with buffer C and bound proteins were eluted by boiling in Laemmli sample buffer. The proteins were resolved by SDS±PAGE and western blotting was performed using anti-TBP (N-12), anti-mSin3B (AK-12), anti-polymerase II (pol II) (C-21) (Santa Cruz) and anti-FLAG (M2) (Sigma) antibodies. 
TBP AS transfection and reporter gene assay
RESULTS
Speci®c binding of NRSF RD-1 (N) and RD-2 (C) with TBP and other transcriptional core factors
We ®rst tested whether the N-or C-terminal repression domain of NRSF could interact with various general transcription factors (see Fig. 1 ). GST pull-down analysis using nuclear extracts of NIH 3T3 cells showed that GST-fused NRSF-N bound to endogenous TBP and TFIIB but that GSTfused NRSF-C bound only to TBP (Fig. 1C) . We also tested possible binding to TFIIF-RAP30, TAFII250, TFIIA and pol II, however, we could not detect any signi®cant binding with GST±NRSF-N or GST±NRSF-C, except RAP30 (data not shown). We next analyzed the direct interaction of NRSF with 35 S-labeled general transcription factors (GTFs) synthesized by in vitro transcription±translation. Consistent with the former results, GST±NRSF-N bound to TBP and TFIIB, whereas GST±NRSF-C bound to TBP only (Fig. 1D) . A weak interaction of NRSF-C with TFIIF-RAP30 was also detected (not shown). When the zinc ®nger motif in NRSF-C (RD-2) was mutated (Cm) or deleted (Cd), this speci®c binding of RD-2 with TBP was abolished, indicating that the interaction of RD-2 with TBP required the C-terminal zinc ®nger motif (Fig. 1D) .
To con®rm the interaction between NRSF and TBP, we further tested whether TBP formed a complex with NRSF in vivo. Co-immunoprecipitation experiments using nuclear extracts of HEK 293 cells overexpressing FLAG-tagged NRSF revealed that TBP was present in the anti-NRSF immunoprecipitates, but not in the preimmune IgG immunoprecipitates as a control (Fig. 1E, a) . To con®rm the speci®city of this binding, we also tested whether pol II, which should not bind, was precipitated with NRSF or not. Only TBP was precipitated by anti-NRSF antibody in the presence of FLAG± NRSF, while pol II was not (Fig. 1E, b) . These results show that TBP formed a complex with NRSF, indicating that TBP is relevant, at least in part, to NRSF-mediated transcriptional repression. The NRSF±TBP complex also seems to be associated with mSin3 (see Fig. 1E, a) .
Identi®cation of TBP-binding regions on NRSF RD-1
To further narrow down the TBP-binding regions on NRSF RD-1, we next performed a GST pull-down assay using the deletion forms of GST-fused NRSF RD-1 ( Fig. 2A) and in vitro translated TBP. The results revealed that GST± NRSF(1±44) was suf®cient for binding to TBP (Fig. 2B) . In a previous study (12) we showed that amino acids 1±44 of NRSF RD-1 did not retain suf®cient repression activity in themselves. Therefore, this result suggests that the interaction of TBP with the NRSF N-terminal region is not essential for the repression activity of RD-1. However, TFIIB and TFIIF-RAP30 bound to GST±NRSF(1±83), but interacted little or not at all with GST±NRSF(1±76), indicating that residues 76±83 of the RD-1 region are required for suf®cient binding to TFIIB or RAP30 (Supplementary Material, Fig. 7S ). These results suggest that interaction of the NRSF RD-1 with TFIIB or TFIIF-RAP30 may be involved in the repression mechanism of RD-1, because residues 76±83 of NRSF were previously shown to be necessary for the repression activity of RD-1 (12).
To test for a possible direct interaction of NRSF with TFIIB, we made TFIIB deletions [the N-terminal region, TFIIB(1± 121); the internal direct repeat, TFIIB(122±215); the C-terminal direct repeat, TFIIB(216±316)] (26). These constructs were radiolabeled by in vitro transcription±translation and then processed for a GST pull-down assay using GSTfused NRSF RD-1 and RD-2 (Supplementary Material, Fig. 7S ). The results revealed that the internal and C-terminal domains of TFIIB bound to NRSF RD-1, whereas NRSF RD-2 interacted weakly with the TFIIB C-terminus. In contrast, the TFIIB N-terminal domain did not bind to NRSF. These results indicate that TFIIB directly interacts with the NRSF RD-1 through internal and/or C-terminal direct repeats of the TFIIB molecule.
NRSF RD-1 and RD-2 bind to the evolutionally conserved H1±H2 and H1¢±H2¢ regions, respectively, on TBP
We next determined the NRSF RD-1-and RD-2-binding regions on TBP. The tertiary structure of TBP has been determined and the conserved C-terminal domain was shown to form a saddle-shaped structure with its underside containing eight antiparallel b-sheets (27) that form the DNA (TATA box)-binding surface of TBP (28, 29) . When TBP is bound to the TATA box, much of the opposite surface of the molecule, including its four a-helices and many of the loops connecting the b-strands, should be available for interaction with other proteins.
To test the possible direct interaction of NRSF with these regions of TBP, we made C-terminal deletion constructs of TBP radiolabeled by in vitro transcription±translation and then performed GST pull-down assays using GST-fused Nucleic
NRSF RD-1 and RD-2 (Fig. 3B) . We ®rst examined four TBP constructs [the full-length TBP(1±335), TBP(1±267), TBP(1± 236) and TBP(1±180)] (Fig. 3C) . TBP(1±267), a construct with H1¢ and H2¢ deleted, still retained a strong af®nity for NRSF-N. TBP(1±236), containing the H1 and H2 regions, showed weak but signi®cant binding to NRSF-N. In contrast, TBP(1±180), containing only H1, showed no interaction with NRSF-N. On the other hand, binding to NRSF-C was detected only with wild-type TBP. To identify the binding region in detail, another series of deletion constructs of TBP were examined for their interaction with NRSF-N (Fig. 3D) and NRSF-C (Fig. 3E) . TBP(1±221), a construct with a deletion from the H2 region to the C-terminal end, and TBP(1±189), with a further deletion, did not bind to NRSF-N (Fig. 3D) . These results indicate that amino acids 221±267 containing the H2 region of TBP are required for the interaction of NRSF RD-1 with TBP. Since no TBP deletion constructs had af®nity for NRSF-C except for full-length TBP [TBP(1±335), Fig. 3E ], NRSF RD-2 seemed to interact with TBP through amino acid residues 279±335 containing the H2¢ region (as summarized in Fig. 3B ). This binding is weaker than that of NRSF-N. However, the speci®city of this binding is also shown in Figure 1D , where Cm and Cd abolished the binding to TBP that was apparent with NRSF-C. In contrast to this binding, when nuclear extracts were used the binding became more apparent compared with that of NRSF-N (Fig. 1D) . This fact may suggest that other factors may also be required for more stable binding between NRSF-C and TBP.
NRSF RD-2 binding to TBP is necessary for repression by NRSF
To monitor the effect of the interaction of NRSF with TBP on repression activity in vivo, we used the altered speci®city TBP assay ®rst described by Strubin and Struhl (30) . This so-called TBP AS assay employs a TBP derivative with a triple amino acid substitution in its DNA-binding surface. This TBP derivative (TBP AS ) has a relaxed DNA-binding speci®city and recognizes an altered TATA box, i.e. TGTA, rather than the normal one. The use of this TBP AS and a TGTA promoter construct allowed us to test the effect of in vitro manipulations of TBP in vivo, as it discriminates between the activity of endogenous wild-type TBP and the manipulated one.
We performed a luciferase assay in Neuro2a cells using human TBP AS and a c-fos TGTA reporter linked to a GAL4± upstream activating sequence (UAS) synthetic enhancer (see Fig. 4A ). At ®rst, we examined the effect of TBP AS in transcriptional repression of a TGTA promoter, using G4 DBD-fused full-length constructs of NRSF [1.5, 7.5, 15 ng (lanes 2±4) and 22.5 ng (lanes 5 and 7] . Compared with modest repression without TBP AS (19% less activity, Fig. 4B , lanes 6 and 7), NRSF effectively repressed transcription of the TGTA promoter in the presence of TBP AS (65% less activity at best, Fig. 4B, lanes 1 and 5) , suggesting that TBP AS is required for effective transcriptional repression mediated by NRSF. To further characterize the mechanism of NRSF repression, we performed this assay using NRSF RD-1 and RD-2. When G4 DBD-fused NRSF RD-1 or RD-2 was added at various concentrations (1, 5 and 10 ng), luciferase activity was decreased in a dose-dependent manner in both cases (Fig. 4C, lanes 2±4 and 5±7 compared with lane 1) . Interestingly, however, the repression activity of RD-2 was completely abolished by the use of a zinc ®nger deletion construct, which had lost its binding activity toward TBP (Fig. 4C, lanes  8±10 ). These results indicate that NRSF RD-2 binding to TBP is essential for the repression activity of RD-2.
NRSF RD-1 binding to TBP is also required for repression by NRSF
We also examined the effect of the NRSF RD-1 interaction with TBP on the repression activity of RD-1. Here we de®ne RD-1 in a broader sense, including the very N-terminal region in addition to the previously de®ned RD-1 for HDAC interaction (12) . Various G4 DBD-fused RD-1 deletion constructs were used for the luciferase assay (Fig. 5A ). G4± NRSF-N (G4±NRN)(1±44), which contained the minimum region for binding to TBP, could not repress transcription, indicating that TBP-binding to NRSF RD-1 is not suf®cient for the repression activity of RD-1 (Fig. 5B, lanes 6 and 7) . G4±NRN(1±83) exhibited very ef®cient repression activity in this assay using TBP AS (lanes 4 and 5), compared with the weak activity of G4±NRN(44±83), which had been identi®ed as the minimum region for NRSF RD-1 repression mediated by the mSin3±HDAC complex in our previous study (12) (lanes 8 and 9) . These results indicate that the binding of TBP to the very N-terminal end of NRSF increases the repression activity of NRSF RD-1, when RD-1 forms a complex including histone deacetylases. Thus, TBP-binding via NRSF-N is required to recruit the NRSF±mSin3±HDAC complex to the core promoter region in the NRSF RD-1-mediated repression mechanism.
Correlation between NRSF binding to TBP and NRSF repression activity
To further test the requirement for NRSF binding to TBP for NRSF-mediated transcriptional repression, we performed GST pull-down and luciferase assays using a series of TBP AS mutants (Fig. 6) . Based upon the results of the aforementioned binding analysis shown in Figure 3 , we used TBP AS mutants that had mutations of residues located on the surface and contained in the binding regions for NRSF-N or NRSF-C of TBP. At ®rst, we analyzed a double substitution mutant of TBP AS , termed H2+S3¢/S4¢ (31). This mutant has three Arg (R)®Ala (A) substitutions at R231A, R235A and R239A on helix 2 and two additional mutations at K297A and R299A in the loop connecting sheet 3¢ with sheet 4¢ in the C-terminal region of TBP. The results of the pull-down assay (Fig. 6B) showed that RD-1 (N) binding to this TBP AS mutant (AS5, lane 7) was signi®cantly decreased compared with that to wild-type TBP AS (AS1, lane 3). In addition, the repression activity of RD-1 was also decreased by this TBP AS mutant (Fig. 6C, lanes 2 and 4) . Next, a TBP AS mutant termed S3¢/S4¢ was tested. This mutant had the same two residue amino acid replacements in the connecting loop as in the above double substitution mutant. The RD-2-binding activity of the TBP AS mutant S3¢/S4¢ (Fig. 6B, lane 12) was decreased compared to wild-type TBP AS (Fig. 6B, AS1, lane 4) and the repression activity of RD-2 was decreased (Fig. 6C, lanes 6 and 8) . These 
results suggest that the repression activities of NRSF RD-1 and RD-2 correlate with their binding activity for TBP. However, we could not detect a signi®cant correlation between the binding to TBP and repression activity with these single point mutants of TBP AS . These results suggest that the NRSF±TBP interaction occurs at multiple residues and/or induces a conformational change in the tertiary structure of the TBP-containing more global complex of the transcriptional initiation machinery.
DISCUSSION
Our experiments demonstrate that NRSF interacts with core promoter factor TBP and that this interaction is required for the transcriptional repression mediated by NRSF. These results indicate that the recruitment of NRSF to the core promoter region is of importance for repression and may allow the NRSF±mSin3±HDAC complex to deacetylate histones located near the promoter region of target genes. In addition, our results suggest that a new HDAC-independent mechanism of repression mediated by a direct interaction between NRSF and TBP is part of the transcriptional regulation by NRSF.
The transcription initiation of any given gene involves an ordered assembly of pol II and other transcription core initiation factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH) to form a preinitiation complex (PIC) on the core promoter (32, 33) . TBP in the TFIID complex binds speci®c-ally to the TATA box to initiate a stepwise assembly of the PIC for pol II transcription. This is followed by the ordered assembly of TFIIA, TFIIB, pol II/TFIIF, TFIIE and TFIIH. The fact that both NRSF RD-1 and RD-2 could bind TBP and, more speci®cally, RD-1 and RD-2 bound as an ordered array along the helical stretches of the so-called`saddle-shaped' structure of TBP may suggest that collaboration of RD-1 and RD-2 is necessary to form a stable inhibitory complex of NRSF±TBP at the promoters of various neuron-speci®c genes. On the other hand, it is also possible that these TBP±RD-1 and TBP±RD-2 interactions occur independently under various circumstances of neuronal differentiation and/or repression. Whichever the case, NRSF seems to interact with TBP at the very ®rst step of pol II transcription.
As to repression by the N-terminal RD-1, it is worth noting that TBP binding occurred at the very N-terminal portion (1±44), whereas the`real' RD-1 with repression activity resided a little downstream and included residues 44± 83 (12) . Since the repression activity of the latter domain was mediated by the interaction with mSin3 and HDAC (12) , the N-terminal region of NRSF (RD-1 in a`broader' sense) could con®rm a large complex with TBP, mSin3 and HDAC. , 2 and 3) , as indicated, were subjected to the pull-down assay. A 10% aliquot of total input protein (I) was loaded as an internal control. (C) A series of TBP AS mutant expression plasmids were co-transfected into Neuro2a cells with GAL4 DBD±NRSF-N (G4-N1±156) (lanes 1±4) or GAL4 DBD±NRSF-C (G4-C989±1097) (lanes 5±8) constructs (1 or 10 ng) and repression activity was analyzed by the luciferase assay. Repression activities were calculated relative to the activity obtained using the GAL4 DBD plasmid as effector.
Nucleic Acids
In a previous study we reported that the repression activity of the C-terminal RD-2 was not released by TSA, suggesting the possibility of a HDAC-independent mechanism (12) . A plausible mechanism would be that the NRSF±TBP interaction inhibits the formation of a transcription PIC by disrupting the interaction between TBP and other core promoter factors, such as TFIIB. This idea is supported by our results for the binding assay between NRSF and general transcription factors (Fig. 1) , showing that RD-2 bound TBP but not TFIIB. In addition, the interaction of NRSF RD-1 with TFIIB may inhibit TFIIB from interacting with the TBP±DNA complex, because RD-1 interacts with the direct repeats region of TFIIB, which is also utilized for formation of the TBP± TFIIB±DNA complex (26) . Recent studies by others have shown interactions between transcription factors or cofactors and general transcription factors. In the absence of its ligand, the thyroid hormone receptor makes contact with components of the general transcription machinery and interferes with formation of the transcription PIC (34) . A SMRT±mSin3 complex directly interacts with TFIIB (35) . In addition, Ikaros, a repressor in the lymphoid system, can repress transcription through interactions with HDAC-independent co-repressors, CtBP and CtIP, which can interact with TBP and TFIIB (36) . More recently, the X-ray structure of Negative cofactor 2 (NC2), a negative regulator of TATA-dependent transcription initiation, was determined as a NC2±TBP±DNA complex, demonstrating that NC2 represses by inhibiting TFIIB from binding to the TBP±TATA element binary complex (37) . In the case of NRSF, the ®rst direct target of NRSF-N (RD-1) and NRSF-C (RD-2) seems to be TBP, and TFIIB would follow TBP and bind to the associated NRSF-N (RD-1). This scheme seems reminiscent of the aforementioned case of the NC2±TBP±TFIIB complex. Three-dimensional structural studies would allow further understanding of the molecular interaction of NRSF and core promoter factors.
So how would the NRSF±TBP interaction in¯uence transcriptional function? One possible mechanism could be that direct interaction between NRSF and TBP prevents binding of TBP to the TATA box of the promoter, which is the ®rst step in assembly of the PIC. A recent study revealed that Mot1, a general transcriptional repressor, prevented the binding of TBP to inactive promoters (38) , whereas transcription activators enhanced TBP binding to promoters and transcriptional activity correlated strongly with the degree of TBP occupancy. In this regard, it is possible that NRSF may inhibit TBP binding. Thus, these reports support the possibility of an NRSF C-terminal repression mechanism acting via direct interaction between NRSF and TBP.
It is interesting to speculate how these dual repression domains, i.e. RD-1 and RD-2, might regulate target genes during neuronal differentiation. Since HDAC-mediated mechanisms require more complex and energy-dependent steps compared with TBP-mediated core factor inhibition, it is possible that the N-terminal domain (RD-1) is used for major regulation, such as expression of genes required for commitment from non-neuronal to neuronal cells in a chromatindependent fashion, whereas the C-terminal domain (RD-2) may regulate the expression of genes required for speci®c neuronal subsets, such as cholinergic or dorpaminergic cells. Otherwise, RD-1 and RD-2 may be utilized in a distinct spatio-temporal manner under various circumstances during the course of neural development. The expression patterns of the mSin3A and CoREST genes during mouse development support this idea. At embryonic day 8.5 (E8.5), mSin3A is expressed widely throughout the embryo, along with NRSF, whereas expression of CoREST is restricted to the head region (15) . Furthermore, TSA treatment released transcription repression of the type II sodium channel gene mediated by the C-terminal domain of NRSF (21) , however, TSA could not release transcriptional repression of the SCG10 and GluR2 glutamate receptor genes (12, 17) . These results suggest that repression of the C-terminal domain of NRSF is multiple and has a distinct promoter-speci®c mechanism. Further study using an in vitro transcription system may allow us to de®ne in more detail the mechanism of NRSF repression with respect to interactions between NRSF and the general transcription factors.
